82 FR 11577 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 36 (February 24, 2017)

[Federal Register Volume 82, Number 36 (Friday, February 24, 2017)]
[Notices]
[Page 11577]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-03647]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcements (FOAs): 
CK17-001, ``Creation of a Healthcare-Associated Infectious Disease 
Modeling Network to Improve Prevention Research and Healthcare 
Delivery''; CK17-002, ``Evaluation of Clinical Interventions, 
Surveillance, and Ecological Factors that Influence the Burden of Human 
Monkeypox in the Democratic Republic of the Congo (DRC)''; and CK17-
004, ``Determining and Monitoring Health Conditions Identified in the 
Medical Assessment of US-Bound Refugees.''
    Time and Date:
10:00 a.m.-5:00 p.m., EDT, March 28-29, 2017 (Closed)

    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Creation of a Healthcare-Associated Infectious Disease Modeling 
Network to Improve Prevention Research and Healthcare Delivery'', CK17-
001; ``Evaluation of Clinical Interventions, Surveillance, and 
Ecological Factors that Influence the Burden of Human Monkeypox in the 
Democratic Republic of the Congo (DRC)'', CK17-002; and ``Determining 
and Monitoring Health Conditions Identified in the Medical Assessment 
of US-Bound Refugees'', CK17-004.
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop 
E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-03647 Filed 2-23-17; 8:45 am]
 BILLING CODE 4163-18-P